Spain is to widen access to treatments for hepatitis C by increasing the eligibility criteria

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.503, 2006-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis C treatment and injecting drug users in Perth, Western Australia: Knowledge of personal status and eligibility criteria for treatment

By Carruthers Susan J.   Ryan Chrissy  

Journal of Substance Use, Vol. 17, Iss. 1, 2012-02 ,pp. : 32-40

Radcliffe Press

Access to resources Recommend Favorite

Emerging treatments for hepatitis C

By Flisiak Robert   Jaroszewicz Jerzy   Parfieniuk-Kowerda Anna  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 4, 2013-12 ,pp. : 461-475

Informa Healthcare

Access to resources Recommend Favorite

The Impact of Antiviral Treatments on the Course of Chronic Hepatitis C: An Evidence-Based Approach

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2123-2130

Bentham Science Publishers

Access to resources Recommend Favorite

Tolerability of Treatments for Viral Hepatitis

By Gervais A.   Boyer N.   Marcellin P.  

Drug Safety, Vol. 24, Iss. 5, 2001-01 ,pp. : 375-384

Adis International

Access to resources Recommend Favorite

Emerging Treatments for Autoimmune Hepatitis

By  

Current Drug Targets. Inflammation & Allergy, Vol. 1, Iss. 4, 2002-12 ,pp. : 317-326

Bentham Science Publishers

Access to resources Recommend Favorite